Almost Clinical

What’s Up, Doc? The Truth About Physician Non-Competes

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 44:22

Physician non-competes aren’t about fairness. They’re about leverage.

In this episode of Almost Clinical, hosts Vincent Buttaci, John Leardi, and Paul Werner break down the reality behind physician restrictive covenants – what they’re supposed to do, what they actually do, and why they’ve gotten so aggressive.

What used to be simple – one year, ten miles – has turned into multi-location, multi-state restrictions that many doctors can’t realistically challenge, even when they should.

So, the real question isn’t just whether these agreements are enforceable.

It’s who can afford to fight them, and who can’t.

The guys explore:

  • What restrictive covenants actually include and what really matters;
  • Why non-competes in healthcare are expanding and who benefits;
  • The “rule of reason” test and why it’s anything but predictable;
  • How private equity has changed the landscape;
  • The real-world problem: most physicians can’t afford to challenge bad contracts;
  • The overlooked stakeholder: patients and their ability to follow their doctor;
  • Why non-solicitation clauses may matter more than non-competes; and
  • Legislative efforts to rein things in and why clarity is still unlikely.

And perhaps most importantly: Why the smartest move often isn’t litigation – it’s negotiation.

Because in a system this fact-specific and this expensive, “winning” in court is rarely the clean outcome anyone thinks it is.

Bottom line: Non-competes in healthcare aren’t just legal issues – they’re business decisions. And increasingly, they’re messy ones.

Join Almost Clinical hosts Vincent Buttaci, John Leardi, and Paul Werner as they challenge each other’s views on how to operate, invest, and succeed in healthcare’s rapidly shifting landscape, translate legalese into business sense for healthcare providers, executives, private equity professionals, and strategic stakeholders, and explore the issues shaping the business of medicine today and tomorrow.